search
Back to results

Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome

Primary Purpose

Iron Deficiency, Restless Leg Syndrome

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Probiotics
Placebo
Sponsored by
Children's Hospitals and Clinics of Minnesota
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Iron Deficiency focused on measuring Iron, Deficiency, Restless, Leg

Eligibility Criteria

5 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Ages 5-18 years
  • RLS defined by NIH criteria -definite or probable (see appendix)
  • Serum ferritin level less than 50 mcg/l
  • CRP less than 10 mg/l

Exclusion Criteria:

  • Immune compromised
  • Milk intolerant/allergic
  • Known allergy or intolerance to probiotics for iron
  • History of hematochromatosis
  • IV catheter or indwelling medical device
  • Chronic gastroenteritis or malabsorption

Sites / Locations

  • Children's Hospitals and Clinics of Minnesota

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Treatment

Control

Arm Description

iron 3 mg/kg/day elemental iron FeSO4 up to 45 mg (dose to be determined by PI) + vitamin C-250 mg chewable tab + probiotics lactobacillus plantarum 299 (1x10x8 colony forming units)

iron 3 mg/kg/day elemental iron FeSO4 to 45 mg + vitamin C-250 mg chewable tab + placebo (identical capsule)

Outcomes

Primary Outcome Measures

Change in Ferritin and CRP Levels

Secondary Outcome Measures

Restless Leg Questionnaire

Full Information

First Posted
March 8, 2012
Last Updated
January 19, 2016
Sponsor
Children's Hospitals and Clinics of Minnesota
search

1. Study Identification

Unique Protocol Identification Number
NCT01617044
Brief Title
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
Official Title
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome-A Double-blind, Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2016
Overall Recruitment Status
Completed
Study Start Date
May 2012 (undefined)
Primary Completion Date
November 2015 (Actual)
Study Completion Date
November 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Children's Hospitals and Clinics of Minnesota

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
A double-blind randomized controlled trial comparing iron plus vitamin C plus probiotic (lactobacillus plantarum 299) to iron plus vitamin C plus placebo in correcting the iron deficiency in children with Restless leg syndrome (RLS) and iron deficiency. One hundred children with diagnosis of RLS will be recruited over a two- year period.
Detailed Description
Project Summary: Iron deficiency is the most common micronutrient deficiency in the world and is associated with significant adverse health effects including: cognitive deficits, immune deficiency, anemia, fatigue, and increased mortality. RLS affects 5 to 10% of adults in the United States and 2% of children. The prevalence of RLS in children with attention deficit hyperactivity disorder (ADHD) is estimated to be 12 to 35%. Iron deficiency has been recognized as an important factor in RLS, and the current recommendation for adults and children with RLS is to maintain serum ferritin level above 50 mcg/l. A common problem in the treatment of iron deficiency is that oral iron is poorly absorbed. Probiotics are a group of microorganisms that benefit the host and are available naturally in fermented foods or as oral supplements. Naturally occurring probiotics, such as yogurt have been used to promote human health for millennia. Probiotic oral supplements have been proven effective and are currently approved for use in pediatrics in the treatment of: acute diarrhea, antibiotic associated diarrhea, and atopy associated with cow milk allergy; and there is some evidence that probiotics may be useful in the treatment of irritable bowel syndrome and necrotizing enterocolitis. In studies in adults, and in cell culture experiments, probiotics have improved iron absorption, but this question has never been studied in children. Relevance: This study proposes to compare the standard treatment for iron deficiency in children (supplemental iron plus vitamin C) with RLS; to supplemental iron plus vitamin C plus probiotics in a randomized, double-blind randomized controlled trial. Specific Aims: To improve the treatment of iron deficiency using oral iron, vitamin C, and probiotics in children with RLS and iron deficiency. To evaluate the safety and monitor for adverse side effects during treatment with probiotics in children with RLS and iron deficiency. Research Question: The research question that this study will address is whether the addition of a specific strain of probiotics (lactobacillus plantarum 299) to the standard treatment of iron deficiency (supplemental iron + Vitamin C) will improve the treatment of iron deficiency. Children with RLS are the study population because RLS is a common diagnosis seen in our sleep center, iron deficiency is a known trigger for RLS, and the current standard of care in the evaluation of patients with RLS is to check serum ferritin level at the time of diagnosis and to treat with supplemental iron if the serum ferritin is < 50 mcg/l. However, the implications of this study go far beyond the treatment of children with RLS and iron deficiency.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Iron Deficiency, Restless Leg Syndrome
Keywords
Iron, Deficiency, Restless, Leg

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
61 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment
Arm Type
Experimental
Arm Description
iron 3 mg/kg/day elemental iron FeSO4 up to 45 mg (dose to be determined by PI) + vitamin C-250 mg chewable tab + probiotics lactobacillus plantarum 299 (1x10x8 colony forming units)
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
iron 3 mg/kg/day elemental iron FeSO4 to 45 mg + vitamin C-250 mg chewable tab + placebo (identical capsule)
Intervention Type
Dietary Supplement
Intervention Name(s)
Probiotics
Intervention Description
probiotics lactobacillus plantarum 299 (1x10x8 colony forming units)
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
Change in Ferritin and CRP Levels
Time Frame
Collection at Baseline and at 6-weeks
Secondary Outcome Measure Information:
Title
Restless Leg Questionnaire
Time Frame
Baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Ages 5-18 years RLS defined by NIH criteria -definite or probable (see appendix) Serum ferritin level less than 50 mcg/l CRP less than 10 mg/l Exclusion Criteria: Immune compromised Milk intolerant/allergic Known allergy or intolerance to probiotics for iron History of hematochromatosis IV catheter or indwelling medical device Chronic gastroenteritis or malabsorption
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gerald Rosen, MD
Organizational Affiliation
Children's Hospitals and Clinics of Minnesota
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospitals and Clinics of Minnesota
City
St. Paul
State/Province
Minnesota
ZIP/Postal Code
55102
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
30732996
Citation
Rosen GM, Morrissette S, Larson A, Stading P, Griffin KH, Barnes TL. Use of a Probiotic to Enhance Iron Absorption in a Randomized Trial of Pediatric Patients Presenting with Iron Deficiency. J Pediatr. 2019 Apr;207:192-197.e1. doi: 10.1016/j.jpeds.2018.12.026. Epub 2019 Feb 4.
Results Reference
derived

Learn more about this trial

Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome

We'll reach out to this number within 24 hrs